Longer-term analysis confirms the clinical benefit of neoadjuvant Nidlegy™ in locally advanced, fully resectable melanoma
The publication represents an update of the PIVOTAL Phase III results previously published in Annals of Oncology, with longer follow-up and additional event-free survival analyses.